• 1
    Wallmark B, Larsson H, Humble L. The relationship between gastric acid secretion and gastric H+,K+-ATPase activity. J Biol Chem 1985;260:1368113684.
  • 2
    Hartmann M, Ehrlich A, Fuder H, et al. Equipotent inhibition of gastric acid secretion by equal doses of oral or intravenous pantoprazole. Aliment Pharmacol Ther 1998;12:10271032.
  • 3
    Larsson H, Carlsson E, Junggren U, et al. Inhibition of gastric acid secretion by omeprazole in the dog and rat. Gastroenterology 1983;85:900907.
  • 4
    Bell NJ, Burget D, Howden CW, et al. Appropriate acid suppression for the management of gastro-oesophageal reflux disease. Digestion 1992;51 (Suppl 1):5967.
  • 5
    Papich M. Papich M. Saunders Handbook of Veterinary Drugs, 2nd ed. St Louis, MO: Elsevier Inc; 2007:476478.
  • 6
    Bersenas A, Mathews K, Allen D, et al. Effects of ranitidine, famotidine, pantoprazole, and omeprazole on intragastric pH in dogs. Am J Vet Res 2005;66:425431.
  • 7
    Abelo A, Eriksson UG, Karlsson MO, et al. A turnover model of irreversible inhibition of gastric acid secretion by omeprazole in the dog. J Pharmacol Exp Ther 2000;295:662669.
  • 8
    Abelo A, Holstein B, Eriksson UG, et al. Gastric acid secretion in the dog: A mechanism-based pharmacodynamic model for histamine stimulation and irreversible inhibition by omeprazole. J Pharmacokinet Pharmacodyn 2002;29:365382.
  • 9
    Rudholm T, Hellstrom P, Theodorsson E, et al. Bravo capsule system optimizes intragastric pH monitoring over prolonged time: Effects of ghrelin on gastric acid and hormone secretion in the rat. World J Gastroenterol 2008;14:61806187.
  • 10
    Yamaguchi T, Seza A, Odaka T, et al. Placement of the Bravo wireless pH monitoring capsule onto the gastric wall under endoscopic guidance. Gastrointest Endosc 2006;63:10461050.
  • 11
    Peters A, Vickers A. The characterization of preclinical research dogs using a combination of pH monitoring and gamma scintigraphy. Delivery Tech 2006;6:5053.
  • 12
    Sagawa K, Li F, Liese R, et al. Fed and fasted gastric pH and gastric residence time in conscious Beagle dogs. J Pharm Sci 2009;98:24942500.
  • 13
    Poulsen KP, Smith GW, Davis JL, et al. Pharmacokinetics of oral omeprazole in llamas. J Vet Pharmacol Ther 2005;28:539543.
  • 14
    Mela GS, Savarino V, Vigneri S. Optimizing the information obtained from continuous 24-hour gastric pH monitoring. Am J Gastroenterol 1992;87:961966.
  • 15
    Huang JQ, Hunt RH. Pharmacological and pharmacodynamic essentials of H(2)-receptor antagonists and proton pump inhibitors for the practising physician. Best Pract Res Clin Gastroenterol 2001;15:355370.
  • 16
    Williamson KK, Willard MD, Payton ME, et al. Efficacy of omeprazole versus high-dose famotidine for prevention of exercise-induced gastritis in racing Alaskan sled dogs. J Vet Intern Med 2010;24:285288.
  • 17
    Lui CY, Amidon GL, Berardi RR, et al. Comparison of gastrointestinal pH in dogs and humans: Implications on the use of the Beagle dog as a model for oral absorption in humans. J Pharm Sci 1986;75:271274.
  • 18
    Yamada I, Haga K. Measurement of gastric pH during digestion of a solid meal in dogs. Chem Pharm Bull (Tokyo) 1990;38:17551756.
  • 19
    Akimoto M, Nagahata N, Furuya A, et al. Gastric pH profiles of Beagle dogs and their use as an alternative to human testing. Eur J Pharm Biopharm 2000;49:99102.
  • 20
    Clary EM, Manson RJ, Lagoo S, et al. Percutaneous cervical oesophageal cannulation in the dog for the performance of prolonged oesophageal pH and manometric studies. Lab Anim 2005;39:435441.
  • 21
    Pandolfino JE, Schreiner MA, Lee TJ, et al. Bravo capsule placement in the gastric cardia: A novel method for analysis of proximal stomach acid environment. Am J Gastroenterol 2005;100:17211727.
  • 22
    Bueno L, Fioramonti J, Ruckebusch Y. Gastric pH changes associated with duodenal motility in fasted dogs. J Physiol 1981;316:319325.
  • 23
    Fackler WK, Vaezi MF, Richter JE. Ambulatory gastric pH monitoring: Proper probe placement and normal values. Aliment Pharmacol Ther 2001;15:11551162.
  • 24
    Chang JH, Choi MG, Yim DS, et al. A novel placement method of the Bravo wireless pH monitoring capsule for measuring intragastric pH. Dig Dis Sci 2009;54:578585.
  • 25
    United States Pharmacopeia Pharmaceutical Compounding – Nonsterile Preparations. USP 32 NF 27, General Chapter 〈795〉. Rockville, MD: United States Pharmacopeia; 2009:314318.
  • 26
    Williamson KK, Willard MD, McKenzie EC, et al. Efficacy of famotidine for the prevention of exercise-induced gastritis in racing Alaskan sled dogs. J Vet Intern Med 2007;21:924927.
  • 27
    Davis MS, Willard MD, Nelson SL, et al. Efficacy of omeprazole for the prevention of exercise-induced gastritis in racing Alaskan sled dogs. J Vet Intern Med 2003;17:163166.